本页面由Tiger Trade Technology Pte. Ltd.提供服务

Travere Therapeutics, Inc.

29.63
-0.7650-2.52%
成交量:35.54万
成交额:1,070.41万
市值:27.33亿
市盈率:-103.46
高:30.74
开:29.89
低:29.39
收:30.39
52周最高:42.13
52周最低:12.91
股本:9,224.16万
流通股本:9,122.00万
量比:1.00
换手率:0.39%
股息:- -
股息率:- -
每股收益(TTM):-0.2864
每股收益(LYR):-0.2864
净资产收益率:-57.80%
总资产收益率:-6.55%
市净率:23.80
市盈率(LYR):-103.46

数据加载中...

2026/02/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/19

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/19

重要事件披露

Form 8-K - Current report
2026/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/13

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities